Tissue-type plasminogen activator is a target of the tumor suppressor gene maspin.
about
Interaction of testisin with maspin and its impact on invasion and cell death resistance of cervical cancer cellsHigh tumoral maspin expression is associated with improved survival of patients with oral squamous cell carcinomaMaspin sensitizes breast carcinoma cells to induced apoptosisMaspin inhibits cell migration in the absence of protease inhibitory activityEvidence for a direct interaction between the tumor suppressor serpin, maspin, and types I and III collagenG-helix of maspin mediates effects on cell migration and adhesionNew, sensitive fluorogenic substrates for human cathepsin G based on the sequence of serpin-reactive site loops.Protein expression profiling identifies maspin and stathmin as potential biomarkers of adenoid cystic carcinoma of the salivary glands.Maspin--a novel protease inhibitor with tumor-suppressing activity in breast cancer.Intracellular serpins in haemopoietic and peripheral blood cells.Identification of an intrinsic determinant critical for maspin subcellular localization and function.Maspin and MCM2 immunoprofiling in salivary gland carcinomasDiscrepancy between mRNA and protein expression of tumour suppressor maspin in synovial tissue may contribute to synovial hyperplasia in rheumatoid arthritis.The emerging role of the thrombin receptor (PAR-1) in melanoma metastasis--a possible therapeutic target.Maspin reprograms the gene expression profile of prostate carcinoma cells for differentiation.Pathobiological significance of vascular endothelial growth factor and Maspin expressions in human gastric carcinoma.Prognostic value of nuclear maspin expression for adjuvant 5-fluorouracil-based chemotherapy in advanced gastric cancerTargeting maspin in endothelial cells to induce cell apoptosis.Prognostic value of maspin mRNA expression in ER alpha-positive postmenopausal breast carcinomasElevated maspin expression is associated with better overall survival in esophageal squamous cell carcinoma (ESCC).Physiological responses to protein aggregates: fibrinolysis, coagulation and inflammation (new roles for old factors).The secretion and biological function of tumor suppressor maspin as an exosome cargo protein.Tissue-type plasminogen activator-mediated plasminogen activation and contact activation, implications in and beyond haemostasis.Maspin: molecular mechanisms and therapeutic implications.Dysregulated ΔNp63α negatively regulates the maspin promoter in keratinocytes via blocking endogenous p73 binding.Decline in the expression of the serine proteinase inhibitor maspin is associated with tumour progression in ductal carcinomas of the breast.p53 regulates cytoskeleton remodeling to suppress tumor progression.The Opportunity of Precision Medicine for Breast Cancer With Context-Sensitive Tumor Suppressor Maspin.Aberrant maspin expression in human endometrial cancer.Cell-type-specific repression of the maspin gene is disrupted frequently by demethylation at the promoter region in gastric intestinal metaplasia and cancer cellsA novel function of tissue factor pathway inhibitor-2 (TFPI-2) in human glioma invasion.Identification of differentially expressed proteins between human hepatoma and normal liver cell lines by two-dimensional electrophoresis and liquid chromatography-ion trap mass spectrometry.Binding of extracellular maspin to beta1 integrins inhibits vascular smooth muscle cell migration.Maspin expression in carcinoma ex pleomorphic adenoma.The diagnostic utility of maspin in the distinction between malignant mesothelioma and pulmonary adenocarcinoma.Maspin expression inversely correlates with breast tumor progression in MMTV/TGF-alpha transgenic mouse model.Maspin expression in stage I and II oral tongue squamous cell carcinoma.Expression of maspin predicts poor prognosis in breast-cancer patients.Maspin expression in CIN 3, microinvasive squamous cell carcinoma, and invasive squamous cell carcinoma of the uterine cervix.Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models.
P2860
Q24301962-9E647AB4-CDA8-4693-ACA1-B7B0F360BA61Q28145302-728B60AF-E9AE-48C6-8F03-57C2F9EB7C36Q28201692-98A7BD84-C742-4DCE-A3BC-759503102391Q28207990-3A73FA39-E0C5-4153-90F1-51EB1E2C4ED0Q28215340-5547AC16-7ABF-42BB-8F31-3E4C854A033EQ30497348-A3125662-7F11-4E7A-B4C9-049E52A1224EQ30696817-F2517ADB-8E44-4AC1-9AE9-DC35B95CD667Q33221534-DD5B2BFF-582D-4A7E-B199-28E4B54170EBQ34156033-101C02F2-9783-4923-8888-F1ACDDE3F54AQ34530137-7E527B36-C337-46CF-AE4A-9FE6F78858A1Q35053115-9CDF5D15-C051-4D6D-8AA4-B151CDB28877Q35318944-0C7DCD76-6FFB-42BB-BB20-27C59AAE45DBQ35553268-8BCA641E-6CFB-4601-8E35-794C58B2928EQ35640140-23D37AB1-1994-4F2E-AD8B-F60323C74ACEQ36047094-07DE014B-60D0-4A9D-A02A-CD5052B90C65Q36065767-EFBB040C-54F6-488D-89A4-4FF2030B2166Q36224775-70834E9F-3A12-4651-8722-DA4164938151Q36481059-F4E59EEA-B6EF-4917-8934-55FD86FE2E6CQ36648801-524A49E9-3831-4BC8-9066-48F9C6F02314Q36867359-9A36712A-4C8E-479E-8172-9D95B3D7090CQ37520011-F57185F5-001C-4007-817D-4F14CC02FE5AQ37702658-77FD4D17-7DBD-42CD-9739-CB61A0B6D6ABQ37903940-82DCF6A2-0638-4BDC-B93F-5AD5951A4CE2Q38023237-19FEC270-F69A-470C-950D-21AB61CE51C0Q38317198-539674C7-3854-4B1C-89B5-9F81717B2BA0Q38459111-7EC355FC-0EA6-47E5-81B5-BE8DC1C651BAQ38553239-4EF5AC82-981E-410F-BB57-1F674A21B2F4Q38927516-26DCD06A-8A77-4B29-B66A-3E04DD0827E5Q40258735-84D397CC-5808-442F-8829-E8769B739F68Q40623145-BEB7B6D6-41ED-44A7-B1B0-A46C9E169C5CQ40771328-D1498F94-329B-4976-9A0E-C0CD19913ADBQ40853089-8D3D17E2-FAE6-4F2A-83EB-7A01372D71E6Q42020559-03CBE4B4-544F-41E1-8F1F-7EBCB2A7B7ACQ42130315-A2C0189E-1BCA-4B11-B858-09EA65178BD2Q42916616-B1D4D509-743C-4160-B594-BF517987459CQ43771758-570C2181-4693-46E1-AD14-975B3C102E07Q43831804-D2D44C9E-2CCF-4D46-BBE4-77F0A23D2266Q44062527-7ADC5A8C-2C58-4668-BB23-ABEB9957E50FQ45282946-FFD0539E-CEBD-4C95-8E8C-911A47A634BCQ51731142-8E18E453-7D04-4709-9298-A10956952AC9
P2860
Tissue-type plasminogen activator is a target of the tumor suppressor gene maspin.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Tissue-type plasminogen activator is a target of the tumor suppressor gene maspin.
@ast
Tissue-type plasminogen activator is a target of the tumor suppressor gene maspin.
@en
type
label
Tissue-type plasminogen activator is a target of the tumor suppressor gene maspin.
@ast
Tissue-type plasminogen activator is a target of the tumor suppressor gene maspin.
@en
prefLabel
Tissue-type plasminogen activator is a target of the tumor suppressor gene maspin.
@ast
Tissue-type plasminogen activator is a target of the tumor suppressor gene maspin.
@en
P2093
P2860
P356
P1476
Tissue-type plasminogen activator is a target of the tumor suppressor gene maspin.
@en
P2093
P2860
P304
P356
10.1073/PNAS.95.2.499
P407
P577
1998-01-01T00:00:00Z